List of Vendor Companies in Austria - 17

Angios is a biotechnology company, specializing in vascular research to improve patients' lives all over the world. We are based in the beautiful city of Innsbruck. We strive to develop new treatments for challenging diabetic vascular diseases by pursuing pre-identified targets for diabetic retinopathy and by leveraging the vascular organoid model developed in the laboratories of our founders.

Astridbio Technologies is a bioinformatics company that specializes in research data-management systems and bioinformatics data-analysis for genomics research.

Austrianova encapsulates living cells in tiny cellulose beads. The beads act as a microenvironment for living cells, allowing them to be metabolically active and divide, whilst being protected from the environment both in vivo (immunoprotection) and in vitro (sheer force, freezing stress protection). Cell-in-a-Box® enables allogenic or xenogenic mammalian cells to be protected from rejection by the immune system, but their porous nature allows therapeutic bioproducts to be released and encapsulated cells to survive for long periods. Cell-in-a-Box® has many advantages e.g. 1) clinically proven safety and efficacy upon implantation of encapsulated cells in patients 2) cells can grow within the capsules in bioreactors and are thus protected from shear forces - especially useful for fragile cells such as stem cells 3) freezing and storage of encapsulated mammalian cells at -80C for more than 5 years and then revival with greater than 90% viability, thus cells can be easily transported on dry ice. Bac-in-a-Box® enables probiotic bacteria and yeast to be encapsulated to protect them from harsh environments. Bac-in-a-Box® has a number of advantages e.g. 1) it is based on a natural polymer which is digestible 2) it totally protects probiotics from low pH as found in the stomach for extended periods (hours), allowing almost 100% of ingested probiotic cells to reach and be released in the lower intestine 3) it allows freeze drying of probiotics without appreciable loss of viability so they can be easily stored and transported at room temperature. We offer cell encapsulation R&D and cGMP production for both - mammalian cells (stem cells, engineered cell lines etc) all the way from the lab to clinical trial material (Cell-in-a-Box®) and for - bacteria and yeast encapsulation for excellent long term storage at ambient temperatures as well as 5 to 7 logs better protection from acid degradation in the stomach and later release in the large intestine (Bac-in-a-Box®).

biocrates is the global leader in mass spectrometry-based quantitative metabolite analysis, with kits and assays covering over 1,000+ metabolites from more than 40 metabolite classes. Our platform combines innovative technology for sample preparation, metabolite identification, and data analysis. The use of quantitative, standardized, and quality-controlled metabolomics methods guarantees robust and reproducible results that are the cornerstones of all clinical research. From just a few microliters of sample material, we can uncover the entire phenotype of an individual and answer a host of questions about systems biology.

Kilobaser is a Biotechnology company that offers in-house DNA and RNA synthesis services with the Kilobaser DNA & RNA Synthesizer for fastest access to molecular tools, producing ready-to-use modified oligos on-demand.

Medical Devices, Small Molecules

Inte:Ligand supports scientists worldwide with innovative approaches for early drug discovery research using computer-aided design solutions. Molecular designers in the pharmaceutical, cosmetic, nutrition, animal health and agro science industries use our solutions to design and identify novel bioactive molecules. We develop the most innovative and user friendly modeling software platforms and provide expert consulting to inspire the innovative process of designing molecules, filtering ideas, and de-risking candidates. Our off the shelf computer-aided design tools include LigandScout, ilib:Diverse, IL PharmDB and the IL Expert KNIME Extensions as well as validated 3D-chemical pharmacophore models for toxicity prediction and precomputed libraries for virtual screening. We provide all of the tools and knowledge you need for successful early drug discovery projects including training and validated workflows to help scientists design and identify bioactive molecules efficiently and productively.

---If you are interested in working with us, please send an application to jobs@medphoton.at We look forward to hearing from you!--- Medphoton is the developer of ImagingRing™ technology, the world´s most innovative and patented solution intended for precise image guided radiotherapy (IGRT). The slim-line system attaches to a robotic patient couch and allows remote imaging of tumours and organs at risk, in both 3D and real time, while the the patient is positioned at the treatment isocenter. Furthermore, the dual energy acquistions and cutting edge spatial resolution provide enhanced soft tissue characterization. In addition, Medphoton´s software provides: - Adaptive Radiotherapy (ART) with online and offline corrections for accurate beam delivery - A multiple client server for Oncology Information Systems (OIS), whereby the image data can be stored, reviewed and archived during radiation therapy, along with treatment plans and dose distributions.

Let's write the future of DNA. Ribbon Biolabs is a biotech start-up working on developing the next technological wave of error-proof DNA synthesis. With its approach, company is developing a cost-efficient platform to produce long and complex DNA molecules, thereby enabling a new generation of biopharmaceutical processes and other synthetic biology products. Our international and highly motivated team located in Vienna is constantly looking for new talents who can join this exciting ride and take Ribbon Biolabs to the next level.

Pioneering Biopharma: Single Use Support provides innovative fluid and cold chain management solutions around single-use technologies for biomanufacturers and CDMOs in the pharmaceutical industry. Our mission is to improve patient safety by providing our customers with products and services that enable our customers to manufacture and transport life-saving liquid pharmaceuticals and drug substances more safely and efficiently around the world. In doing so, we contribute to the most valuable process of all: Curing diseases & saving lives. We offer specific expertise and fast solutions in processes related to advanced cell and gene therapies (CGT), as well as commercial bulk drug substance handling and vaccine manufacturing transfers and drug productions. Our product range includes single-use bioprocess containers, single-use assemblies, protective shells (RoSS) as secondary packaging for bioprocessing single-use bags, freeze-thaw platforms, fill-drain platforms, 3D bag totes, ultra-cold storage, transport containers and more.

At TAmiRNA we drive innovation through microRNA and RNAi technology to solve unmet clinical needs. Circulating microRNAs are novel minimal-invasive biomarkers that fulfil the requirements of valuable markers. TAmiRNA excels in the identification and development of microRNA biomarkers for diagnosis and prediction of disease and treatment response with a special focus on musculoskeletal, cardiovascular and metabolic diseases. TAmiRNA is a biotech R&D company based in Vienna, Austria. ---- Privacy Policy and Imprint can be accessed by clicking "Contact us" ----

At Technoclone we see innovation as our duty to help overcome new complexity in the diagnostics of hematological and cardio-vascular disorders. Today more than ever. Technoclone is a world-leading producer of diagnostics tests; equipment’s and research products in the area of blood clotting and offers one of the most complete product portfolios on the market. The Ceveron 100 series is the first fully automated coagulation analyzer series for clotting, chromogenic, turbidimetric assays, thrombin generation and quenching technology (as for FXIII & ADAMTS13 activity). With the development of the new high power LED quenching module the Ceveron s100 is a milestone in speciality haemostasis diagnostics. Technoclone, on the forefront of diagnostic challenges of tomorrow.

ThioMatrix is specialised on the development of non-invasive drug delivery systems utilizing its core technologies: the Thiomer Technology and SEDDS Technology. Due to the great potential of these technologies the efficacy of non-invasively delivered: -therapeutic peptides -peptidomimetics -nucleic acids such as oligonucleotides, plasmid DNA and siRNA -class III drugs according to the biopharmaceutical classification system (BCS) -drugs being substrate of efflux pumps such as anticancer drugs can be tremendously improved. A wide network of partnerships and collaborations with hospitals, veterinary institutions, CROs and universities has been established to conduct preclinical through to clinical development of our delivery products. This network coupled to our technologies and expertise gives us the edge to reduce the time to market to develop the optimal delivery systems for your therapeutic candidates. To learn more about our drug delivery technologies, please visit the technology section where you will also find the results of various in vivo studies demonstrating the advantages of our novel drug delivery products.

VALANX Biotech is a biotechnology company based in Graz, Austria, founded in 2017 as a spin-off from Graz University of Technology. The company specializes in site-specific protein conjugation, focusing on advancing biologics development through synthetic biology and genetic code expansion. VALANX operates additional lab facilities at the Vienna Biocenter. The company offers a patented protein conjugation platform that allows precise control over conjugation sites and modifications on target proteins. This technology incorporates non-natural amino acids, enabling the development of protein-drug conjugates, diagnostics, and biocatalysis products. VALANX aims to create biologics for therapeutic and diagnostic applications, particularly in cancer drug targeting, with the capability of up to 10 selectable conjugation sites per protein. The company collaborates with partners to enhance reproducibility and cost efficiency in conjugate development and has raised $2.56 million in funding.

VelaLabs - founded 2006 - is a GLP and GMP-certified and G(C)LP compliant contract laboratory focusing on analytical and quality services of biopharmaceutical products supporting BIOTECH and PHARMA companies in the clinical development of biosimilars, biologics and ATMPs. By the acquisition of LABH in 2019 and building a clean room in 2020, VelaLabs also offers all types of microbiological services. Together with its strong team, the VelaLabs Management aims to successfully realize its vision of being a trusted partner for our customers along the process of medication development.

ViennaLab Diagnostics is a medical diagnostics company that develops and manufactures user-friendly in-vitro diagnostic products for human genetic testing, specializing in assays for detecting genetic variants associated with genetic disorders and pharmacogenetics.

Digitize the patient journey with XUND's API-first medical devices and guide your patients to the right decision. From prevention to diagnosis and monitoring.